Compare Jabil Inc (JBL) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jabil Inc vs Moderna, Inc. — how do they compare? Jabil Inc trades at $362.37 (market cap $37.37B), while Moderna, Inc. trades at $60.5 (market cap $24.18B). The key difference: Jabil Inc is the larger of the two by market cap, and Jabil Inc pays a 0.09% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| JBL | MRNA | |
|---|---|---|
Market Cap | $37.37B | $24.18B |
Sector | Technology | Health |
52-Week High | $385.50 | $81.80 |
52-Week Low | $192.49 | $22.36 |
Enterprise Value | $39.90B | $20.33B |
Dividend Yield | 0.09% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jabil Inc
Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.
Read more on JBL →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
